UnitedHealthcare Extends Coverage to Abbott ’s Unique Neurostimulation Therapy for Nerve Pain

- Abbott ’s Proclaim™ dorsal root ganglion (DRG) neurostimulation system is the only FDA-approved DRG technology for the treatment of CRPS I and causalgia of the lower extremitiesi
Source: Abbott.com - Category: Pharmaceuticals Source Type: news